Cases and Literature Review of Timing for Withdrawal of Palliative Chemotherapy

  • Jeong Y
  • Kim D
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Advanced incurable cancer patients receive palliative chemotherapy to prolong their life and improve quality of life. However, physicians should assess the timing to discontinue the treatment, especially near the final months of life, as palliative chemotherapy may accompany considerable toxicity. Even though there are no clear guidelines regarding the withdrawal timing for anticancer treatment in palliative setting, it is important clarify the issue for quality of care for advanced cancer patients. Here, we present two patients who received palliative chemotherapy for advanced colon cancer and non-small cell lung cancer, respectively. In both cases, it was jointly determined to stop palliative chemotherapy, and best efforts are made to relieve troublesome symptoms. The cases and up-to-date literature review will highlight the importance of the timing of discontinuation of cancer treatments when changes are being made to the health care system and hospice and palliative medicine is taking root in Korea.

Cite

CITATION STYLE

APA

Jeong, Y. J., & Kim, D. Y. (2016). Cases and Literature Review of Timing for Withdrawal of Palliative Chemotherapy. The Korean Journal of Hospice and Palliative Care, 19(1), 70–75. https://doi.org/10.14475/kjhpc.2016.19.1.70

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free